U.S. Markets closed

Ra Medical Systems, Inc. (RMED)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
3.8700+0.5500 (+16.57%)
At close: 3:59PM EDT

3.7800 -0.09 (-2.33%)
After hours: 4:08PM EDT

Ra Medical Systems, Inc.

2070 Las Palmas Drive
Carlsbad, CA 92011
United States
760 804 1648
http://www.ramed.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees85

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan Will McGuireCEO & Director799.48kN/A1963
Mr. Andrew C. JacksonChief Financial Officer711.66kN/A1969
Mr. Daniel HorwoodGen. Counsel & Sec.577.19kN/A1974
Ms. Tiah ReppasVP, Chief Accounting Officer & Corp. ControllerN/AN/AN/A
Ms. Maria Villanueva SessionsVP & Compliance OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Corporate Governance

Ra Medical Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.